195 related articles for article (PubMed ID: 1685012)
1. Beta-adrenoceptors in the transplanted human heart: unaltered beta-adrenoceptor density, but increased proportion of beta 2-adrenoceptors with increasing posttransplant time.
Brodde OE; Khamssi M; Zerkowski HR
Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):430-6. PubMed ID: 1685012
[TBL] [Abstract][Full Text] [Related]
2. Decrease in beta 1- and increase in beta 2-adrenoceptors in long-term follow-up after orthotopic cardiac transplantation.
Steinfath M; von der Leyen H; Hecht A; Neumann KH; Schmitz W; Scholz H; Haverich A; Heublein B
J Mol Cell Cardiol; 1992 Oct; 24(10):1189-98. PubMed ID: 1336061
[TBL] [Abstract][Full Text] [Related]
3. Development of beta-adrenoceptor number and subtype distribution in the transplanted human heart.
Zerkowski HR; Khamssi M; Brodde OE
Eur Heart J; 1991 Dec; 12 Suppl F():124-6. PubMed ID: 1666551
[TBL] [Abstract][Full Text] [Related]
4. Specific non-beta-adrenergic binding sites for 125I-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat, and porcine hearts.
Bjørnerheim R; Golf S; Hansson V
Cardiovasc Res; 1991 Sep; 25(9):764-73. PubMed ID: 1666020
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte beta 2-adrenoceptors mirror precisely beta 2-adrenoceptor, but poorly beta 1-adrenoceptor changes in the human heart.
Michel MC; Beckeringh JJ; Ikezono K; Kretsch R; Brodde OE
J Hypertens Suppl; 1986 Dec; 4(6):S215-8. PubMed ID: 2886571
[TBL] [Abstract][Full Text] [Related]
6. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists.
Kitagawa Y; Adachi-Akahane S; Nagao T
Br J Pharmacol; 1995 Sep; 116(1):1635-43. PubMed ID: 8564230
[TBL] [Abstract][Full Text] [Related]
7. Regional distribution of beta-adrenoceptors in the human heart: coexistence of functional beta 1- and beta 2-adrenoceptors in both atria and ventricles in severe congestive cardiomyopathy.
Brodde OE; Schüler S; Kretsch R; Brinkmann M; Borst HG; Hetzer R; Reidemeister JC; Warnecke H; Zerkowski HR
J Cardiovasc Pharmacol; 1986; 8(6):1235-42. PubMed ID: 2434752
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of 125I-iodocyanopindolol binding to beta-adrenergic and serotonin-1B receptors of rat brain: selectivity of beta-adrenergic agents.
Tsuchihashi H; Nakashima Y; Kinami J; Nagatomo T
Jpn J Pharmacol; 1990 Feb; 52(2):195-200. PubMed ID: 1968985
[TBL] [Abstract][Full Text] [Related]
9. Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart.
Juberg EN; Minneman KP; Abel PW
Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):193-202. PubMed ID: 2865685
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenoceptors in equine trachea and heart.
Töneke K
Vet Res Commun; 1999 Jan; 23(1):41-51. PubMed ID: 10905817
[TBL] [Abstract][Full Text] [Related]
11. Beta 1-adrenoceptor selectivity of nebivolol and bisoprolol. A comparison of [3H]CGP 12.177 and [125I]iodocyanopindolol binding studies.
Bundkirchen A; Brixius K; Bölck B; Nguyen Q; Schwinger RH
Eur J Pharmacol; 2003 Jan; 460(1):19-26. PubMed ID: 12535855
[TBL] [Abstract][Full Text] [Related]
12. Characterization of rat cerebral cortical beta adrenoceptor subtypes using (-)-[125I]-iodocyanopindolol.
Tiong AH; Richardson JS
J Recept Res; 1989-1990; 9(6):495-508. PubMed ID: 2577008
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic pindolol treatment on human myocardial beta 1- and beta 2-adrenoceptor function.
Bjørnerheim R; Golf S; Hansson V
Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):429-35. PubMed ID: 2175014
[TBL] [Abstract][Full Text] [Related]
14. Ligand binding properties of putative beta 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes.
Sillence MN; Moore NG; Pegg GG; Lindsay DB
Br J Pharmacol; 1993 Aug; 109(4):1157-63. PubMed ID: 8104645
[TBL] [Abstract][Full Text] [Related]
15. The role of a low beta 1-adrenoceptor selectivity of [3H]CGP-12177 for resolving subtype-selectivity of competitive ligands.
Nanoff C; Freissmuth M; Schütz W
Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):519-25. PubMed ID: 2893983
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterisation of beta-adrenoceptors on intact equine peripheral blood lymphocytes with the radioligand (-)-[125I]-iodocyanopindolol.
Abraham G; Broddet OE; Ungemach FR
Equine Vet J; 2001 Sep; 33(5):487-93. PubMed ID: 11558744
[TBL] [Abstract][Full Text] [Related]
17. Changes in cardiac beta-adrenoceptors in human heart diseases: relationship to the degree of heart failure and further evidence for etiology-related regulation of beta 1 and beta 2 subtypes.
Steinfath M; Lavicky J; Schmitz W; Scholz H; Döring V; Kalmár P
J Cardiothorac Vasc Anesth; 1993 Dec; 7(6):668-73. PubMed ID: 7905755
[TBL] [Abstract][Full Text] [Related]
18. Characterization and autoradiographic localization of beta-adrenoceptor subtypes in human cardiac tissues.
Buxton BF; Jones CR; Molenaar P; Summers RJ
Br J Pharmacol; 1987 Oct; 92(2):299-310. PubMed ID: 2823947
[TBL] [Abstract][Full Text] [Related]
19. Hypertrophic cardiomyopathy: a desensitized cardiac beta-adrenergic system in the presence of normal plasma catecholamine concentrations.
Schumacher C; Becker H; Conrads R; Schotten U; Pott S; Kellinghaus M; Sigmund M; Schöndube F; Preusse C; Schulte HD
Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):398-407. PubMed ID: 7630430
[TBL] [Abstract][Full Text] [Related]
20. Identification of beta 2-adrenoceptors on guinea pig alveolar macrophages using (-)-3-[125I]iodocyanopindolol.
Leurs R; Beusenberg FD; Bast A; Van Amsterdam JG; Timmerman H
Inflammation; 1990 Aug; 14(4):421-6. PubMed ID: 1974244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
